Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus intraperitoneal dexmedetomidine with intraperitoneal bupivacaine for pain after laparoscopic cholecystectomy
IRCT20160307026950N53Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine and bupivacaine in postoperative pain (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: VAS pain score, Additional analgesic dose and 3 more. Started Jul 2023; status: completed.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20160307026950N53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N53.